BOM:524636 (India)
Â
Shs Dematerialised
₹
36.50
(+4.11%)
Jun 14
Current and historical daily PE Ratio for Oxygenta Pharmaceutical Ltd (
) from 1994 to Jun 17 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Oxygenta Pharmaceutical stock (BOM:524636) PE ratio as of Jun 17 2024 is 0.
More Details
Oxygenta Pharmaceutical Ltd (BOM:524636) PE Ratio (TTM) Chart
Oxygenta Pharmaceutical Ltd (BOM:524636) PE Ratio (TTM) Historical Data
View and export this data going back to 1994. Start your Free Trial
Total 1261
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Oxygenta Pharmaceutical PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-17 | At Loss | 2024-04-08 | At Loss |
| 2024-06-14 | At Loss | 2024-04-05 | At Loss |
| 2024-06-13 | At Loss | 2024-04-04 | At Loss |
| 2024-06-12 | At Loss | 2024-04-03 | At Loss |
| 2024-06-11 | At Loss | 2024-04-02 | At Loss |
| 2024-06-10 | At Loss | 2024-04-01 | At Loss |
| 2024-06-07 | At Loss | 2024-03-28 | At Loss |
| 2024-06-06 | At Loss | 2024-03-27 | At Loss |
| 2024-06-05 | At Loss | 2024-03-26 | At Loss |
| 2024-06-04 | At Loss | 2024-03-22 | At Loss |
| 2024-06-03 | At Loss | 2024-03-21 | At Loss |
| 2024-05-31 | At Loss | 2024-03-20 | At Loss |
| 2024-05-29 | At Loss | 2024-03-19 | At Loss |
| 2024-05-28 | At Loss | 2024-03-18 | At Loss |
| 2024-05-27 | At Loss | 2024-03-14 | At Loss |
| 2024-05-24 | At Loss | 2024-03-13 | At Loss |
| 2024-05-23 | At Loss | 2024-03-12 | At Loss |
| 2024-05-22 | At Loss | 2024-03-11 | At Loss |
| 2024-05-21 | At Loss | 2024-03-07 | At Loss |
| 2024-05-17 | At Loss | 2024-03-06 | At Loss |
| 2024-05-16 | At Loss | 2024-03-05 | At Loss |
| 2024-05-15 | At Loss | 2024-03-04 | At Loss |
| 2024-05-14 | At Loss | 2024-03-01 | At Loss |
| 2024-05-13 | At Loss | 2024-02-29 | At Loss |
| 2024-05-10 | At Loss | 2024-02-28 | At Loss |
| 2024-05-09 | At Loss | 2024-02-27 | At Loss |
| 2024-05-08 | At Loss | 2024-02-26 | At Loss |
| 2024-05-07 | At Loss | 2024-02-23 | At Loss |
| 2024-05-06 | At Loss | 2024-02-22 | At Loss |
| 2024-05-03 | At Loss | 2024-02-21 | At Loss |
| 2024-05-02 | At Loss | 2024-02-20 | At Loss |
| 2024-04-30 | At Loss | 2024-02-19 | At Loss |
| 2024-04-29 | At Loss | 2024-02-16 | At Loss |
| 2024-04-26 | At Loss | 2024-02-15 | At Loss |
| 2024-04-25 | At Loss | 2024-02-14 | At Loss |
| 2024-04-24 | At Loss | 2024-02-13 | At Loss |
| 2024-04-23 | At Loss | 2024-02-12 | At Loss |
| 2024-04-22 | At Loss | 2024-02-09 | At Loss |
| 2024-04-19 | At Loss | 2024-02-08 | At Loss |
| 2024-04-18 | At Loss | 2024-02-07 | At Loss |
| 2024-04-16 | At Loss | 2024-02-06 | At Loss |
| 2024-04-15 | At Loss | 2024-02-05 | At Loss |
| 2024-04-12 | At Loss | 2024-02-02 | At Loss |
| 2024-04-10 | At Loss | 2024-02-01 | At Loss |
| 2024-04-09 | At Loss | 2024-01-31 | At Loss |
Oxygenta Pharmaceutical Ltd (BOM:524636) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Oxygenta Pharmaceutical Ltd
ISIN : INE102E01018
Share Class Description:
BOM:524636: Shs DematerialisedCompare
Compare
Traded in other countries / regions
524636.India IPO Date
1994-10-07Description
Oxygenta Pharmaceutical Ltd is a pharmaceutical company. It is engaged in the business activity of manufacturing bulk drugs and API. It specializes in manufacturing anti ulcerative and anti-bacterial drugs. The Company has one reportable segment which is Pharmaceutical. The group carries its business operations within India.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers